Dana-Farber Cancer Institute (together with its affiliates, “Dana-Farber,” “us,” “we,” or “our”) takes steps to provide for the accessibility and usability of this website and all digital assets contained or offered therein (collectively, our “Digital Content”). To this end, we work to provide Digital Content that is compatible with commonly used assistive browsers, tools, and technologies. As part of our ongoing efforts to update our Digital Content based on current technology and other restrictions, we welcome your feedback related to the functionality or accessibility of our Digital Content.
This statement applies to all Digital Content produced or updated by Dana-Farber. Note that the Digital Content may contain links to external websites and/or third-party content that is not within Dana-Farber’s control and may not follow the same accessibility policies and standards Dana-Farber follows. We are not responsible for these websites and/or third-party content. Links to any other party’s website or content do not constitute or imply an endorsement or recommendation by Dana-Farber of the linked website or content.
If you have questions, concerns or feedback related to the functionality or accessibility of the Digital Content, please email us at email@example.com or call 617-632-3000.
When you contact us, please be sure to tell us:
To the extent your feedback warrants a further response from us, or if we need additional information to process your feedback, we will respond to you through a communication method that works for you and is consistent with applicable law.
While Dana-Farber strives to adhere to the accepted guidelines and standards of accessibility and usability, please be aware that as technology continues to evolve, it may not always be possible to do so in all areas of Dana-Farber’s Digital Content. We are, however, committed to seeking accessibility solutions as an ongoing effort.
Last Updated March 3, 2023